Aleksandra O. Nikiforova

Aleksandra O. Nikiforova

Auto-generated profile, based on publicly available information

Aleksandra O. Nikiforova

Federal Research and Clinical Center for Infectious Diseases

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
VGV. A. Greshnyakova
V. A. Greshnyakova
LGL. G. Goriacheva
L. G. Goriacheva
ANA. O. Nikiforova
A. O. Nikiforova
Инфекционный мононуклеоз: нетипичная манифестация

20 November 2023 in Marine Medicine
Verified
Journal Article
Open access
PDF file
NENatalya A. Efremova
Natalya A. Efremova
ANAlexandra O. Nikiforofa
Alexandra O. Nikiforofa
VGVera A. Greshnyakova
Vera A. Greshnyakova
НОНикифорова Александра Олеговна
Никифорова Александра Олеговна
INTRODUCTION. The human gut microbiota is a set of microorganisms that are in symbiosis with the host organism. The predominance of bacteria of Bacteroidetes, Firmicutes, Actinobacteria types is a characteristic feature of human gut microbiota. However, the composition of the gut microbiota is subject to change under the influence of a number of factors. The influence of the gut-liver axis on the pathogenesis of many chronic liver diseases of various etiologies, both infectious and metabolic, has been proven. At the same time, in the analyzed literature, the data on the relationship between the nature of GM changes and the stage of liver damage are quite controversial. OBJECTIVE. Updating and systematization of ideas about the nature of changes in the composition of intestinal microbiota in chronic hepatitis C (CHC) and non-alcoholic fatty liver disease (NAFLD) at different stages of the disease. MATERIALS AND METHODS. We analyzed the scientific literature on GM changes in chronic liver diseases with regard to their etiology and disease stage, in particular in chronic viral hepatitis C and NAFLD. The search was conducted in PubMed, Google Scholar, and eLIBRARY databases for 2000-2023 using the following keywords: gut microbiota; microbiota in hepatitis C; microbiota in NAFLD; microbiota in liver fibrosis; liver fibrosis progression. Sixty scientific articles were analyzed and 42 sources were selected, of which more than 60% were published within the last five years. RESULTS. This review presents the results of original studies describing the main taxonomic differences between the microbiomes of healthy individuals and patients with CHC complicated by the formation of liver cirrhosis and hepatocellular carcinoma (HCC). Thus, patients with viral cirrhosis showed impoverishment of intestinal commensals Lachnospiraceae and Ruminococcaceae and significant enrichment of Streptococcaceae, Lactobacillaceae and Enterobacteriaceae. In patients with non-alcoholic steatohepatitis (NASH) and FII, enrichment of GM Phylum Bacteroides and Proteobacteria, Families Lachnospiraceae and Enterobacteriaceae, Genera Blautia and Escherichia, with a concomitant decrease of Prevotella was detected. DISCUSSION. The analysis of GM taxonomic units in the previously described studies did not reveal significant differences depending on the etiology of the underlying disease. However, a decrease in the representative of the phylum Firmicutes - Ruminococcaceae was observed in CHC in contrast to NAFLD. A more distinct relationship can be observed in the changes of intestinal microbiota in F(III-IV) irrespective of etiology. Thus, in advanced liver fibrosis and cirrhosis of both CHC and NAFLD etiologies, enrichment of GM has been described due to an increase in phylum Proteobacteria, in particular the genus Escherichia and phylum Firmicutes (Blautia, Veillonellaceae). In the studies analyzed, at F(III-IV), an enrichment of the microbiota is observed due to an increase in the phylum Bacteroidetes. Regarding the genus Prevotella, contradictory results were found. In addition, there are ambiguous data regarding the genera Lactobacillus, Ruminococcaceae and Bifidobacteria. CONCLUSION. Based on the results of the literature review, we obtained contradictory data on GM composition in patients with CHC and NAFLD. This may be due to the size of samples, heterogeneity of initial data during the selection of patients in the study. The relationship between the composition of microbiota and persistent inflammatory process, expressed liver fibrosis is observed. GM reflects not only functional disorders in chronic liver diseases of various etiologies, but can also serve as a diagnostic indicator of their progression.

15 February 2020 in Epidemiology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
EEElena V. Esaulenko
Elena V. Esaulenko
KNKseniya E. Novak
Kseniya E. Novak
TIThierry Ingabire
Thierry Ingabire
SSSof’yA A. Semenova
Sof’yA A. Semenova
ANAleksandra O. Nikiforova
Aleksandra O. Nikiforova
ИТИнгабире Тьерри
Ингабире Тьерри
Aim: to demonstrate the difficulties and timeliness of HIV diagnosis by primary care physicians, to carry out a clinical and epidemiological analysis of newly diagnosed cases of HIV infection. Materials and methods: The study evaluated the routing of diagnosis and analyzed the epidemiological and clinical and laboratory data of 85 patients with a newly diagnosed HIV infection hospitalized in the St. Petersburg Clinical Infectious Diseases Hospital named after S. P. Botkin during the period from November 2018 to October 2019. To confirm positive results, ELISA and western blot were used. Results: Among the observed patients, 71.3% were women and 28.7% were men. The average age was 39.3 2 years. Upon admission to the infectious diseases hospital with an established diagnosis of HIV infection, 49.5% were hospitalized in specialized departments (n = 42). Of them, nine (9) were referred by the polyclinic with an established diagnosis, in 20 patients the diagnosis was established in somatic hospitals, and emergency room doctors newly diagnosed HIV infection in 13 more patients. The remaining 50.5% (n = 43) were hospitalized in various departments with other diagnoses. Clinical and laboratory analysis of these patients showed that for the first time in life, an established diagnosis of HIV infection corresponded to both early (15.3%) and late (84.7%) stages of the disease with dominance of sexual transmission of the virus (43.6%). Conclusion: HIV infection at both early and late stages can manifest under the guise of various other diseases, which makes it necessary to expand testing of patients for HIV infection, including using rapid tests.

27 November 2025 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
ANA. O. Nikiforova
A. O. Nikiforova
VGV. A. Greshnyakova
V. A. Greshnyakova
KZK. V. Zhdanov
K. V. Zhdanov
LGL. G. Goryacheva
L. G. Goryacheva
The Aim: To analyze the state of lipid metabolism, body composition, and liver parenchyma structure in children with chronic hepatitis C (СHC). Methods . The study group consisted of 63 children with СHC aged 3—17 years without concomitant endocrine pathology, who were examined in 2022—2024 at the NCCIB. The control group consisted of 37 healthy children aged 9—17 years. All underwent anthropometry, laboratory examination (HCV RNA PCR, lipidogram), liver elastography with assessment of steatosis. Results . Children with СHC are significantly more likely to have hypolipidemia in the form of a decrease in total cholesterol and low-density lipoprotein (LDL) levels (p < 0.05), while in healthy children there is a decrease in high-density lipoproteins (HDL) and an increase in the coefficient of atherogenicity (p < 0.05). In the study group, abnormalities in lipid metabolism were found in 39.6% of children, while the majority (64%) had a «healthy weight». An increase in the level of non-HDL cholesterol was more often recorded in children with a «healthy weight» and was associated with genotypes 1 and 2 (non-3) of the virus (p < 0.05). Almost half (43.2%) of children with СHC had liver steatosis associated with the non-3 genotype of the virus (p < 0.05). Children with СHC without obesity are significantly more likely to develop steatosis compared with the control group (p < 0.05). Conclusions . Virus-induced changes in lipid metabolism parameters, regardless of the presence or absence of overweight, associated with the non-3 genotype of the virus, were found in children with СHC. Hypolipidemia is significantly associated with HCV. Liver steatosis is significantly more common in children with СHC without excess weight compared to healthy children, which further confirms the effect of the virus on the lipid profile.